Algorithmiq develops quantum algorithms and interfaces that integrate classical and quantum computing to accelerate research in healthcare and life sciences. The company focuses on chemistry and drug discovery, materials science, and related life-science applications, using quantum computing to tackle complex, atomistic-scale problems. It promotes a Digital Quantum Interface to connect quantum hardware with existing computational workflows. Headquartered in Finland, Algorithmiq positions itself at the intersection of quantum computing and biomedical innovation.
No recent deals for this company.